185 related articles for article (PubMed ID: 22415709)
21. Calpains: markers of tumor aggressiveness?
Roumes H; Leloup L; Dargelos E; Brustis JJ; Daury L; Cottin P
Exp Cell Res; 2010 May; 316(9):1587-99. PubMed ID: 20193680
[TBL] [Abstract][Full Text] [Related]
22. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
24. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
[TBL] [Abstract][Full Text] [Related]
25. Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.
Kephart JJ; Tiller RG; Crose LE; Slemmons KK; Chen PH; Hinson AR; Bentley RC; Chi JT; Linardic CM
Clin Cancer Res; 2015 Nov; 21(21):4868-80. PubMed ID: 26071485
[TBL] [Abstract][Full Text] [Related]
26. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
[TBL] [Abstract][Full Text] [Related]
27. SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
Saini M; Verma A; Mathew SJ
Cell Death Dis; 2018 Feb; 9(2):237. PubMed ID: 29445192
[TBL] [Abstract][Full Text] [Related]
28. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.
Woods GM; Bondra K; Chronowski C; Leasure J; Singh M; Hensley L; Cripe TP; Chakravarti A; Houghton P
Pediatr Blood Cancer; 2015 Sep; 62(9):1550-1554. PubMed ID: 25790258
[TBL] [Abstract][Full Text] [Related]
31. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
[TBL] [Abstract][Full Text] [Related]
32. The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity.
Thuault S; Comunale F; Hasna J; Fortier M; Planchon D; Elarouci N; De Reynies A; Bodin S; Blangy A; Gauthier-Rouvière C
Mol Biol Cell; 2016 Sep; 27(17):2653-61. PubMed ID: 27413008
[TBL] [Abstract][Full Text] [Related]
33. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma].
Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B
Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436
[TBL] [Abstract][Full Text] [Related]
34. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma.
Venkatramani R; Triche TJ; Wang L; Shimada H; Mascarenhas L
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e356-60. PubMed ID: 26056800
[TBL] [Abstract][Full Text] [Related]
36. PAX3-FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis.
Zeng FY; Cui J; Liu L; Chen T
Cancer Lett; 2009 Nov; 284(2):157-64. PubMed ID: 19442434
[TBL] [Abstract][Full Text] [Related]
37. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
[TBL] [Abstract][Full Text] [Related]
38. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
[TBL] [Abstract][Full Text] [Related]
39. Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma.
Rossi F; Legnini I; Megiorni F; Colantoni A; Santini T; Morlando M; Di Timoteo G; Dattilo D; Dominici C; Bozzoni I
Oncogene; 2019 May; 38(20):3843-3854. PubMed ID: 30670781
[TBL] [Abstract][Full Text] [Related]
40. c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells.
Kaspar P; Prochazka J; Efenberkova M; Juhasz A; Novosadova V; Sedlacek R
Sci Rep; 2019 Apr; 9(1):6342. PubMed ID: 31004084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]